Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series

ConclusionATTM could be a good treatment for the initial treatment of WD with neurological symptoms due to its high efficacy, with a lower rate of neurological deterioration than the drugs currently available, despite the potential adverse effects.

Source: Brain and Behavior - March 24, 2020 Category: Neurology Authors: Oriol De Fabregues, Jaume Vi ñas, Antoni Palasí, Manuel Quintana, Ignasi Cardona, Cristina Auger, Víctor Vargas Tags: ORIGINAL RESEARCH Source Type: research